Gmax Biopharm
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.gmaxbiopharm.comRevenue
<$5 MillionIndustry
About Gmax Biopharm
About Gmax Biopharm LLC.: Gmax is a clinical stage biopharmaceutical company established in 2010 and headquartered in Hangzhou, China. It's a global company focusing on R&D, production and commercialization of antibody drugs targeting GPCRs. Gmax mainly works on cardiovascular, metabolic and cancer areas. Currently there are five drug development programs in different stages of clinical trials: GMA102 (type 2 diabetes), GMA105 (obesity), GMA301A (PAH for adult), GMA301B (PAH for children), GMA106 (obesity/T2DM/NASH). GMA131, an ETA specific ERA mAb for DKD/CKD, is about to enter into phase 1/2 trial in China and USA. Gmax's unique M-body technology empowers acting on two or more different targets to improve drug efficacy or broaden indications.Explore more
SIC Code 28,283NAICS Code 32,325Show moreGmax Biopharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Gmax Biopharm Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gmax Biopharm
Sign Up For FreeTo access detailed company insights
About Gmax Biopharm LLC.: Gmax is a clinical stage biopharmaceutical company established in 2010 and headquartered in Hangzhou, China. It's a global company focusing on R&D, production and commercialization of antibody drugs targeting GPCRs. Gmax mainly works on cardiovascular, metabolic and cancer areas. Currently there are five drug development p... Read More
